organ transplant rejections

kidney transplant organ
Biotech

Cell therapy allows kidney recipients to cut immunosuppressants

Medeor’s kidney transplant cell therapy allowed more than half of study participants in a phase 3 trial to stay off immunosuppressants for two years.
Annalee Armstrong Nov 2, 2023 10:00am
Organ transplant

Immunosuppressant antibody curbs chronic transplant rejection

Apr 24, 2023 11:05am
layoffs job cuts workforce reduction layoff

Talaris lays off 95% of workforce after fruitless deal hunt

Apr 17, 2023 9:38am
organ transplant surgery cooler organ transplantation

Talaris ends recently restarted kidney transplant studies

Feb 16, 2023 11:00am